Document Type

Article

Department

Centre of Excellence in Women and Child Health; Obstetrics and Gynaecology (East Africa)

Abstract

Background:Evidence on caffeine citrate (CC) for apnoeaof prematurity (AOP) originate from high-income countries. This study aimed to develop consensus on research design for evidence in sub-Saharan Africa (SSA).

Methods:We surveyed physicians in newborn units across SSA to assess their opinions on CC research and their preferred study designs.

Participants rated four study designs:a) an observational before-and-after study; a randomized controlled trial (RCT) of b) caffeine versus placebo; c) caffeine versus aminophylline; d) a traditional or stepped wedge cluster trial.  They  assessed  each  design  using  a  Likert  scale  for  evidence, feasibility, and ethics considerations.

Results:Ninety-two   newborn   physicians   across   21   SSA   countries participated.  Most  respondents  (72%)  felt  a  trial  on  CC  in  SSA  was important.  An  RCT  of  CC  vs.  aminophylline  and  a  cluster  RCT  had  the highest ratings for importance (82% and 73%), feasibility (75% and69%), and  ethical  appropriateness  (78%  and  69%),  while  an  RCT  of  CC  vs. placebo received the lowest ratings in these categories.

Conclusions:Newborn SSA physicians agree that local research on CC is needed  and rated  an  individual  or  cluster RCT comparing  caffeine  with aminophylline to evaluate CC's impact on key clinical outcomes.

Publication (Name of Journal)

Medical Research Archives

DOI

https://doi.org/10.18103/mra.v14i3.7360

Creative Commons License

Creative Commons Attribution 4.0 International License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Share

COinS